Table 3. Crude and adjusted prevalence ratios or the use of at least one drug by self-medication, according to demographic, socioeconomic aspects, health conditions indicators and access to health services indicators. PNAUM, Brazil, 2014. (N = 40,833).
| Variable | Crude PR | 95%CI | p | Adjusted PR | 95%CI | p |
|---|---|---|---|---|---|---|
| Gender | < 0.001 | < 0.001 | ||||
| Male | 1 | 1 | ||||
| Female | 1.44 | 1.31–1.59 | 1.33 | 1.21–1.47 | ||
| Age group (years) | < 0.001 | < 0.001 | ||||
| 0-9 | 1 | 1 | ||||
| 10-19 | 1.89 | 1.54–2.33 | 2.03 | 1.66–2.47 | ||
| 20-39 | 3.25 | 2.72–3.89 | 3.46 | 2.94–4.08 | ||
| 40-59 | 2.68 | 2.22–3.21 | 2.68 | 2.26–3.17 | ||
| ≥ 60 | 2.15 | 1.78–2.59 | 1.95 | 1.63–2.34 | ||
| Color | < 0.001 | 0.045 | ||||
| White | 1 | 1 | ||||
| Black | 1.19 | 1.04–1.37 | 0.93 | 0.81–1.07 | ||
| Yellow | 1.63 | 1.25–2.13 | 1.11 | 0.88–1.40 | ||
| Brown | 1.11 | 1.00–1.23 | 0.90 | 0.82–1.00 | ||
| Indigenous | 1.93 | 1.18–3.16 | 1.37 | 0.89–2.12 | ||
| Education (years) | < 0.001 | |||||
| 0-8 | 1 | |||||
| 9-11 | 1.37 | 1.17–1.43 | ||||
| ≥ 12 | 1.37 | 1.15–1.52 | ||||
| Economic classification* | 0.858 | |||||
| D/E | 1 | |||||
| A/B | 1.03 | 0.90–1.20 | ||||
| C | 1.03 | 0.93–1.13 | ||||
| Region | < 0.001 | 0.001 | ||||
| North | 1.56 | 1.27–1.92 | 1.76 | 1.44–2.16 | ||
| Northeast | 2.10 | 1.79–2.44 | 2.33 | 2.00–2.72 | ||
| Southeast | 1.12 | 0.92–1.36 | 1.18 | 0.97–1.42 | ||
| South | 1 | 1 | ||||
| Midwest | 1.18 | 1.44–1.98 | 1.74 | 1.49–2.04 | ||
| No. chronic diseases | < 0.001 | < 0.001 | ||||
| 0 | 1 | 1 | ||||
| 1 | 1.33 | 1.20–1.48 | 1.17 | 1.06–1.29 | ||
| ≥ 2 | 1.33 | 1.20–1.47 | 1.33 | 1.18–1.50 | ||
| Health insurance | 0.708 | |||||
| No | 1 | |||||
| Yes | 1.03 | 0.90–1.18 | ||||
| Hospitalized in the previous year | < 0.001 | |||||
| No | 1 | |||||
| Yes | 1.29 | 1.14–1.47 |
* According to the 2013 Brazilian Economic Classification Criterion of the Brazilian Association of Research Companies (www.abep.org).